The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
![Netherlands Netherlands flag](https://www.greenhill.com/sites/default/files/niederland.gif)
Veen Bosch & Keuning
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advising Veen Bosch & Keuning, the largest book publisher in the Netherlands, on its sale to Simon & Schuster, one of the world’s preeminent publishing houses
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Liontown Resources Limited
![flag not available](https://www.greenhill.com/sites/default/files/n_a_flag.gif)
Advised Australian-based lithium company Liontown Resources Limited on its A$590m debt facility to fund the Kathleen Valley Lithium Project
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
myHomecare Group
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Advising Australian Unity on its acquisition of myHomecare Group
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Liontown Resources Limited
![flag not available](https://www.greenhill.com/sites/default/files/n_a_flag.gif)
Advised Australian-based lithium company Liontown Resources Limited on its A$390m equity raising to fund the Kathleen Valley Lithium Project
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Liontown Resources Limited
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advising Australian-based lithium company Liontown Resources Limited on its response to change of control proposals from Albemarle Corporation
![Spain Spain flag](https://www.greenhill.com/sites/default/files/spain.gif)
Farmalider Group
![Spain Spain flag](https://www.greenhill.com/sites/default/files/spain.gif)
Advising the shareholders of Grupo Farmalider, a B2B Spanish pharmaceutical company focused on contract manufacturing, innovation and development of products based on generics, on the sale of an undisclosed stake to local private equity MCH
![France France flag](https://www.greenhill.com/sites/default/files/france.gif)
Synfonium / Qwant / Shadow
![France France flag](https://www.greenhill.com/sites/default/files/france.gif)
Advised Banque des Territoires / Groupe Caisse des Dépôts (CDC), a French Public Institution, on the investment in the newly created platform Synfonium, incorporating Shadow, a cloud-based platform, and Qwant, a sovereign search engine. CDC will hold a 25% stake in Synfonium, while Octave Klaba and Miroslaw Klaba, the co-founders of OVHcloud, will hold the remaining 75%
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Marley Spoon business combination with 468 SPAC II
![Germany Germany flag](https://www.greenhill.com/sites/default/files/germany.gif)
Advising Marley Spoon SE, an ASX listed global subscription-based meal kit provider, on its business combination agreement with 468 SPAC II, simultaneous capital raising and amendment to existing debt facilities
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Kyowa Kirin International’s testosterone replacement therapy drug, Tostran®
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Advising Kyowa Kirin International, a subsidiary of Kyowa Kirin Co., Ltd, a Japanese global specialty pharma company, on the divestiture of its testosterone replacement therapy drug, Tostran®, to Advanz Pharma, a privately-held, specialty pharmaceutical company
![](https://www.greenhill.com/sites/default/files/greece-uk.png)
Clinigen Ltd’s Lamda Laboratories
![Germany Germany flag](https://www.greenhill.com/sites/default/files/germany.gif)
Advising Clinigen Ltd, a UK-based global pharmaceutical services company and portfolio company of Triton Partners, on the sale of Lamda Laboratories, a European contract development business, to Adragos Pharma, a Munich-based pharmaceutical CDMO
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Annovera®, Imvexxy®, Bijuva®, and prescription prenatal vitamin products
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Advised TherapeuticsMD, Inc., an innovative, leading women’s healthcare company on definitive agreements to license its products to Mayne Pharma
![Germany Germany flag](https://www.greenhill.com/sites/default/files/germany.gif)
Exyte Management GmbH
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advising Stumpf Capital and Georg Stumpf on the sale of a minority interest in its wholly-owned company, Exyte, a global leader in the design, engineering and delivery of high-tech facilities, to funds affiliated with BDT Capital Partners
![](https://www.greenhill.com/sites/default/files/philippines_0_0.png)
Portfolio of Towers from PLDT
![](https://www.greenhill.com/sites/default/files/philippines_0_0.png)
Advising Unity Digital Infrastructure Inc., a leading Philippine-based joint venture telecommunications infrastructure platform by Aboitiz InfraCapital and Partners Group, on the acquisition of 650 towers from PLDT, one of the largest telecommunication service providers in the Philippines, through a sale and leaseback transaction
![](https://www.greenhill.com/sites/default/files/uk-japan.png)
Kyowa Kirin International’s established medicines business
![Germany Germany flag](https://www.greenhill.com/sites/default/files/germany.gif)
Advising Kyowa Kirin International, a subsidiary of Kyowa Kirin Co., Ltd, a Japanese global specialty pharma company, on a collaboration agreement with Grünenthal GmbH, a global, science-based, privately-owned pharmaceutical company
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
OZ Minerals Limited
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Advising Australian-based copper company OZ Minerals Limited, on its response to two change of control proposals from BHP Group Limited, the world’s largest diversified resources company
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Minnesota Rubber and Plastics
![Sweden Sweden flag](https://www.greenhill.com/sites/default/files/sweden.gif)
Facilitated the sale of KKR’s portfolio company Minnesota Rubber and Plastics, a leading provider of materials science-based elastomer and thermoplastic solutions, to Trelleborg
![USA/Germany U.S.A., Germany flags](https://www.greenhill.com/sites/default/files/usa_germany.gif)
Precision Surfacing Solutions
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Precision Surfacing Solutions, a leading manufacturer of precision surface finishing equipment and related aftermarket parts and services, on its sale to Bison Capital and Angeles Equity
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Wildstone
![France France flag](https://www.greenhill.com/sites/default/files/france.gif)
Advising DigitalBridge, one of the largest global digital infrastructure investors, on the sale of Wildstone, Europe’s largest owner of independent outdoor media infrastructure, to Antin Infrastructure Partners
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Liontown Resources
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Liontown Resources, an ASX-listed lithium company focused on the development of the world-class Kathleen Valley Lithium Project, on a lithium spodumene concentrate offtake agreement and A$300m financing facility from Ford Motor Company
![Spain Spain flag](https://www.greenhill.com/sites/default/files/spain.gif)
San Sebastian Bus Station
![Spain Spain flag](https://www.greenhill.com/sites/default/files/spain.gif)
Advised Oak Hill Advisors on the sale of the San Sebastian bus station
![Ireland Ireland flag](https://www.greenhill.com/sites/default/files/ireland.gif)
NAC 33 & NAC 34, subsidiaries of Nordic Aviation Capital
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Azorra Aviation, a leading commercial aircraft lessor backed by Oaktree Capital Management, on the chapter 11 restructuring and related investment in NAC 33 & 34, two exiting subsidiaries of Nordic Aviation Capital
![](https://www.greenhill.com/sites/default/files/philippines_0_0.png)
Portfolio of Towers from PLDT
![Malaysia Malaysia flag](https://www.greenhill.com/sites/default/files/malaysia_63832.gif)
Advising edotco Group, the leading pan-Asian telecom tower infrastructure company, on the acquisition of 2,973 towers from PLDT, one of the largest telecommunication service providers in the Philippines, through a sale and leaseback transaction
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Syrah Resources
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advisor to Syrah Resources, an ASX-listed industrial minerals and technology company, on its US$107mm loan from the U.S. Department of Energy under the Advanced Technology Vehicles Manufacturing loan program to fund the initial expansion of its Vidalia active anode material facility in Louisiana, USA
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
DGO Gold
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Advising DGO Gold, an ASX-listed gold exploration company, on its recommended, off-market takeover offer from Gold Road Resources, an ASX-listed gold producer
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Acacia Pharma Group plc
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advising Acacia, a UK-domiciled and Euronext-listed commercial stage biopharmaceutical company, on the sale to Eagle Pharmaceuticals, an integrated pharmaceutical company with R&D, manufacturing and commercial expertise